Medanta - Public Comps and Valuation Multiples

Medanta Overview

About Medanta

Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.

Founded

2004

HQ

Employees

9.7K+

Website

medanta.org

Sectors

Hospitals & Clinics

Financials

LTM Revenue $460M

LTM EBITDA $110M

EV

$4.1B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Medanta Financials

As of September 2025, Medanta reported last 12-month revenue of $460M and EBITDA of $110M.

In the same period, Medanta generated $351M in LTM gross profit and $65.7M in net income.

See Medanta valuation multiples based on analyst estimates

Medanta P&L

In the most recent fiscal year, Medanta reported revenue of $410M and EBITDA of $102M.

Medanta expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Medanta valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$460M	XXX	$410M	XXX	XXX	XXX
Gross Profit	$351M	XXX	$311M	XXX	XXX	XXX
Gross Margin	76%	XXX	76%	XXX	XXX	XXX
EBITDA	$110M	XXX	$102M	XXX	XXX	XXX
EBITDA Margin	24%	XXX	25%	XXX	XXX	XXX
EBIT	$88.3M	XXX	$83.1M	XXX	XXX	XXX
EBIT Margin	19%	XXX	20%	XXX	XXX	XXX
Net Profit	$65.7M	XXX	$54.3M	XXX	XXX	XXX
Net Margin	14%	XXX	13%	XXX	XXX	XXX
Net Debt	XXX	XXX	$11.0M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Medanta including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $460M. EBITDA for the last twelve months was $110M. In the most recent fiscal year, Medanta achieved $410M in revenue and $102M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$460M	Analyst estimates available to subscribers	$410M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$351M	Analyst estimates available to subscribers	$311M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	76.5% gross margin	Analyst estimates available to subscribers	75.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$110M	Analyst estimates available to subscribers	$102M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	23.8% EBITDA margin	Analyst estimates available to subscribers	24.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$88.3M	Analyst estimates available to subscribers	$83.1M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	19.2% EBIT margin	Analyst estimates available to subscribers	20.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$65.7M	Analyst estimates available to subscribers	$54.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	14.3% net profit margin	Analyst estimates available to subscribers	13.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$11.0M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Medanta

This financial data table provides comprehensive performance metrics for Medanta, a company based in India. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Medanta generated $460M in revenue over the last twelve months.
The company achieved $110M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $351M.
Net income over the last twelve months reached $65.7M.

Fiscal Year Performance

In the most recent fiscal year, Medanta reported $410M in total revenue.
Fiscal year EBITDA was $102M.
The company maintained a gross profit margin of 75.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 24.9%.
Net profit margin reached 13.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Medanta. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Medanta Stock Performance

Medanta has current market cap of INR 369B (or $4.2B), and EV of INR 365B (or $4.1B).

Market Cap Evolution

Medanta Stock Data

As of October 17, 2025, Medanta's stock price is INR 1372 (or $15).

See Medanta trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$4.1B	$4.2B	XXX	XXX	XXX	XXX	$0.25

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Medanta Valuation Multiples

Medanta's trades at 10.3x EV/Revenue multiple, and 40.7x EV/EBITDA.

See valuation multiples for Medanta and 15K+ public comps

Medanta Financial Valuation Multiples

As of October 17, 2025, Medanta has market cap of $4.2B and EV of $4.1B.

Equity research analysts estimate Medanta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Medanta has a P/E ratio of 63.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$4.2B	XXX	$4.2B	XXX	XXX	XXX
EV (current)	$4.1B	XXX	$4.1B	XXX	XXX	XXX
EV/Revenue	9.0x	XXX	10.3x	XXX	XXX	XXX
EV/EBITDA	37.6x	XXX	40.7x	XXX	XXX	XXX
EV/EBIT	46.7x	XXX	50.8x	XXX	XXX	XXX
EV/Gross Profit	11.7x	XXX	n/a	XXX	XXX	XXX
P/E	63.3x	XXX	76.7x	XXX	XXX	XXX
EV/FCF	302.9x	XXX	559.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Medanta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Medanta Margins & Growth Rates

Medanta's last 12 month revenue growth is 17%

Medanta's revenue per employee in the last FY averaged $42K, while opex per employee averaged $24K for the same period.

Medanta's rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Medanta's rule of X is 66% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Medanta and other 15K+ public comps

Medanta Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	17%	XXX	18%	XXX	XXX	XXX
EBITDA Margin	24%	XXX	25%	XXX	XXX	XXX
EBITDA Growth	20%	XXX	16%	XXX	XXX	XXX
Rule of 40	42%	XXX	42%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	66%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$42K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$24K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	1%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	0%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	56%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial